Search - tctmd.com

Displaying 301 - 320 of 806

Sort: Relevancy | Date

Presentation TCT 2017

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

Presenter: Alaide Chieffo, Jeffrey W. Moses, Martin B. Leon

October 30, 2017

Presentation TCT 2017

Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival

Presenter: Dean J. Kereiakes, Spencer B. King III, Lorenz Raber

October 30, 2017

Presentation TCT 2017

Keynote Lecture: A Brief 40-Year History of PCI - How Far We've Come, How Far We Have to Go

Presenter: Dean J. Kereiakes, Spencer B. King III, Robert A. Byrne

October 30, 2017

Presentation TCT 2017

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

Presenter: Julinda Mehilli, Giulio G. Stefanini, Sunil V. Rao

October 30, 2017

Presentation TCT 2017

Small Vessel Stenting Snapshot 1: The Onyx 2.0 Zotarolimus-Eluting Stent

Presenter: Julinda Mehilli, Giulio G. Stefanini, Matthew J. Price

October 30, 2017

Presentation TCT 2017

Outcomes With the Stentys Self-Expanding DES in STEMI and Other Clinical Scenarios

Presenter: Julinda Mehilli, Giulio G. Stefanini, Roxana Mehran

October 30, 2017

Presentation TCT 2017

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Presenter: Julinda Mehilli, Giulio G. Stefanini, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

Emerging Thromboresistant BMS 2: Titanium-Nitride-Oxide Stents

Presenter: Julinda Mehilli, Giulio G. Stefanini, Pim A.L. Tonino

October 30, 2017

Presentation TCT 2017

Emerging Thromboresistant BMS 1: Cobra PzF Stents

Presenter: Julinda Mehilli, Giulio G. Stefanini, Donald Cutlip

October 30, 2017

Presentation TCT 2017

Should BMS Stay On the Shelf? Clinical and Global Perspectives on the Role Of BMS in 2017

Presenter: Julinda Mehilli, Giulio G. Stefanini, Raffaele Piccolo

October 30, 2017

Presentation TCT 2017

Case #4: Central Venous Stents: When, Which, and How (With Discussion)

Presenter: Mahmood K. Razavi

October 30, 2017

Presentation TCT 2017

Novel Technique: Use of Mother in Child Guideliner Catheter as a Conduit for Optimal Visualization and Deployment of Stents in Coronary Ostial Lesions

Presenter: Peter L Duffy, Yuejin Yang, Harinder K Bali

October 30, 2017

Presentation TCT 2017

Iliac Vein Compression: Indications and Techniques for Venous Stents (Case Reviews)

Presenter: Michael R. Jaff, Robert A. Lookstein, Sanjiv Lakhanpal

October 30, 2017

Presentation ESC 2017

BIOFLOW V Comparison of Ultrathin Sirolimus-Eluting Bioresorbable Polymer with Thin Everolimus-Eluting Durable Polymer Stents

Presenter: David E Kandzari

September 13, 2017

Presentation iASSESS 2017

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

Presenter: Rajesh V. Swaminathan, Dmitriy N. Feldman

August 30, 2017

Presentation

Self-Expanding vs Balloon-Expandable Stents for Iliac Artery Occlusive Disease: ICE trial

August 25, 2017

Presentation EuroPCR 2017

Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China

Presenter: Runlin Gao

May 17, 2017

Presentation

Economic Outcomes of Absorb BVSvs Everolimus-Eluting Stents in PCI

April 18, 2017

Presentation Fellows 2017

The Evolution of Drug-Eluting Stents

Presenter: Ajay J. Kirtane

April 07, 2017

Presentation

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

February 13, 2017

Advertisement

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival

Keynote Lecture: A Brief 40-Year History of PCI - How Far We've Come, How Far We Have to Go

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

Small Vessel Stenting Snapshot 1: The Onyx 2.0 Zotarolimus-Eluting Stent

Outcomes With the Stentys Self-Expanding DES in STEMI and Other Clinical Scenarios

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Emerging Thromboresistant BMS 2: Titanium-Nitride-Oxide Stents

Emerging Thromboresistant BMS 1: Cobra PzF Stents

Should BMS Stay On the Shelf? Clinical and Global Perspectives on the Role Of BMS in 2017

Case #4: Central Venous Stents: When, Which, and How (With Discussion)

Novel Technique: Use of Mother in Child Guideliner Catheter as a Conduit for Optimal Visualization and Deployment of Stents in Coronary Ostial Lesions

Iliac Vein Compression: Indications and Techniques for Venous Stents (Case Reviews)

BIOFLOW V Comparison of Ultrathin Sirolimus-Eluting Bioresorbable Polymer with Thin Everolimus-Eluting Durable Polymer Stents

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

Self-Expanding vs Balloon-Expandable Stents for Iliac Artery Occlusive Disease: ICE trial

Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China

Economic Outcomes of Absorb BVSvs Everolimus-Eluting Stents in PCI

The Evolution of Drug-Eluting Stents

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content